GLPG
Galapagos NV ADR
NASDAQ: GLPG · HEALTHCARE · BIOTECHNOLOGY
$27.86
-1.97% today
Updated 2026-04-29
Market cap
$1.91B
P/E ratio
5.00
P/S ratio
1.72x
EPS (TTM)
$5.69
Dividend yield
—
52W range
$25 – $38
Volume
0.2M
Galapagos NV ADR (GLPG) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$27.86
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$316.70
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.5B | $0.2B | $0.2B | $0.3B | $1.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 5.00x (capped 25x) · Margin: 28.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.